Ipsen delivers solid results in 2024, driven by strong performance across all therapeutic areas, and provides guidance for 2025

PARIS, FRANCE, 13 February 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the full year 2024.